Tumors are highly heterogeneous entities, both morphologically and functionally. This
heterogeneity applies to the primary tumor and to systemic metastasis. The tumoral …

Positron emission tomography (PET) is an imaging technique, which allows for accurate non-
invasive measurements of metabolic pathways in tissues of man in vivo. The most frequently …

The d-glucose analog 2-(fluorine-18)-fluoro-2-deoxy-d-glucose (FDG) is the most commonly
used radionuclide in positron emission tomography (PET) of lung cancer. FDG-PET is a …

Over the past several years, positron emission tomography (PET) has become a clinically
useful, noninvasive study which complements conventional imaging (chest radiographs …

An estimated 180,000 new cases of lung cancer will be diagnosed in the United States this
year, and lung cancer accounts for approximately 25% of all cancer deaths. The overall 5 …

This article reviews the role of 18 F-2-deoxy-d-glucose (FDG) positron emission tomography
(PET) imaging in staging, radiation therapy planning, and determination of prognosis and …

An estimated 180,000 new cases of lung cancer will be diag nosed in the US this year, and
lung cancer accounts for approximately 25% of all cancer deaths. Most lung cancers are …

This concise, excellently illustrated pocket book provides an up-to-date summary of the
science and practice of PET/CT imaging in lung cancer. The coverage encompasses the …

Lung cancer has been the leading cause of cancer-related mortality in China in recent
decades. Positron emission tomography-computer tomography (PET/CT) has been …

Abstract 18 F-fluorodeoxyglucose (FDG) PET imaging provides physiologic and metabolic
information that characterizes lesions that are indeterminate by CT. FDG PET imaging is …